At this time, posts about Myeongmun Pharmaceutical are rapidly increasing on portals and securities communities. Today, foreigners have tentatively sold a net 175,000 shares of Myeongmun Pharmaceutical, while institutions have bought a net 1,000 shares. Myeongmun Pharmaceutical is known as a comprehensive pharmaceutical company specializing in prescription drugs.

As of 12:30 PM on the 5th, Myeongmun Pharmaceutical's stock price is 6.0% higher than the previous day at 6,540 KRW, with a trading volume of 20,336,851 shares, which is 882.13% of the average trading volume on the 5th.

In addition to Myeongmun Pharmaceutical, posts by investors are also rapidly increasing for Hanmi Pharm (128940), Green Cross Holdings 2 Preferred (005257), and VIDI (148140).

※Source: AI Investment Assistant AI Racciro

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing